Advanced Biomed Inc.
ADVB
$0.42
$0.001.16%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -70.57% | 90.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -56.79% | 58.97% | |||
| Operating Income | 56.79% | -58.97% | |||
| Income Before Tax | 44.85% | 49.30% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 44.85% | 49.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 44.85% | 49.30% | |||
| EBIT | 56.79% | -58.97% | |||
| EBITDA | 58.55% | -67.70% | |||
| EPS Basic | 44.75% | 52.07% | |||
| Normalized Basic EPS | 44.83% | 51.90% | |||
| EPS Diluted | 44.75% | 52.07% | |||
| Normalized Diluted EPS | 44.83% | 51.90% | |||
| Average Basic Shares Outstanding | 0.03% | 5.64% | |||
| Average Diluted Shares Outstanding | 0.03% | 5.64% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||